RxDoctor Payments Data

Jennifer Datzko, NP

Nurse Practitioner · Bay City, MINPI 1568005569

Payments from drug & device makers

$666in general payments, 2019–2025

Across 43 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$164
  • AstraZeneca$77
  • Biohaven Pharmaceuticals, Inc.$74
  • Otsuka America Pharmaceutical, Inc.$61
  • AbbVie$53
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$48
  • plus $189 from 8 others

What the payments were for

  • Food & beverage$665100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$666 in reported general payments places this provider in the 75th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Medicare billing

Part B allowed, 2024
$100,121
Medicare patients
407
Services billed
1,372

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide72$76,675
EliquisApixaban63$49,214
XareltoRivaroxaban45$37,868
LinzessLinaclotide48$31,119
RexultiBrexpiprazole24$25,786
JardianceEmpagliflozin24$19,087
JanuviaSitagliptin Phosphate26$18,543
OzempicSemaglutide16$16,576
PrilosecOmeprazole Magnesium12$11,604
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,670
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$8,657
MyrbetriqMirabegron14$8,157
Icosapent Ethyl28$6,626
SymbicortBudesonide/Formoterol Fumarate24$5,909
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen226$5,608

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$164$76,67572 claims
AbbVieLinzess$53$31,11948 claims
Otsuka America Pharmaceutical, Inc.Rexulti$61$25,78624 claims
Novo NordiskOzempic$26$16,57616 claims
AstraZenecaSymbicort$77$5,90924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Bay City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →